SELLAS Life Sciences SLS Cash Flow Statement (2010-2026)

NASDAQ SLS
$14.04 +0.34 (+2.48%)
As of: Sep 4, 2026 · 12:49 PM EDT
Reported Financials

SELLAS Life Sciences Quarterly Cash Flow Statement

Periods 65 quarters
Latest Jun 2026

SELLAS Life Sciences reported cash from operations of -$7.59M and free cash flow of -$7.59M for the quarter ended Jun 2026, down 3.5% year over year. This cash flow statement covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-6.98M-11.62M-16.73M-8.62M-7.15M-9.45M-11.28M-8.84M-9.27M-8.14M-9.57M-7.47M-7.11M-6.74M-5.81M-6.60M-6.79M-7.66M-8.41M-9.61M
Share-based Compensation
0.28M0.29M0.45M0.38M0.46M0.45M0.54M0.51M0.54M0.50M0.48M0.33M0.38M0.37M0.51M0.50M0.50M0.45M0.80M1.01M
Deferred Taxes
Cash from Discontinued Operations
Asset Writedowns and Impairment
Cash from Operations
-5.88M-4.98M-7.15M-5.76M-5.75M-5.15M-12.13M-7.57M-6.89M-4.83M-10.76M-9.68M-7.81M-7.15M-9.07M-7.33M-7.10M-4.90M-8.85M-7.59M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles
0.04M0.08M0.21M0.12M0.09M0.16M0.12M0.13M0.14M0.14M0.14M0.15M0.15M0.15M0.15M0.15M0.15M0.15M
Depreciation & Amortization (CF)Depreciation & Amortization
Change in Working Capital
Change in Receivables
1.00M
Change in Inventory
Change in Account Payables
0.27M-0.40M0.67M0.53M-1.21M1.23M-0.28M0.66M0.61M1.32M1.81M-1.06M-1.77M-1.12M0.28M-0.44M-1.03M0.66M0.69M-0.55M
Change in Accured Expenses
0.80M0.06M0.15M0.21M1.56M1.72M0.20M-0.24M0.69M0.81M-1.04M-1.43M0.31M-0.02M-2.90M-0.49M0.90M0.55M-1.26M1.64M
Other Working Capital Changes
0.25M-1.01M0.61M-0.74M-0.37M-0.75M1.47M-0.35M-0.54M-1.10M2.44M0.07M-0.38M-0.34M1.13M0.29M0.64M-1.09M0.65M0.09M
Investing Activities
Capital Expenditures
Acquisitions
Divestments
Change in Acquisitions & Divestments
Cash from Investing Activities
-3.00M
Financing Activities
Other financing activities
0.00M0.05M0.05M0.04M0.05M0.05M0.05M0.35M0.15M0.00M0.50M4.21M17.32M29.02M44.10M0.10M
Debt Issuance and Repayment
Long-Term Debt Issuances
Long-Term Debt Repayments
Change in Capital Stock
Shares Issued
Net Shares Issued and Repurchased
Net Equity Issued and Repurchased
2.24M0.05M0.07M0.93M0.27M0.02M
Dividend Payments
Dividends Paid - Common
Misc.
Cash from Financing Activities
2.24M0.05M0.05M23.00M0.11M0.93M18.90M-0.03M0.05M3.39M26.65M0.41M19.69M0.01M23.58M4.23M26.09M32.39M44.15M38.83M
Change in Cash
-3.64M-4.93M-7.10M12.73M-5.64M-4.22M6.78M-10.10M-9.84M-1.44M15.88M-9.27M11.88M-7.14M14.51M-3.10M19.02M27.47M35.30M31.25M
Free Cash Flow
-5.88M-4.98M-7.15M-5.76M-5.75M-5.15M-12.13M-7.57M-6.89M-4.83M-10.76M-9.68M-7.81M-7.15M-9.07M-7.33M-7.10M-4.90M-8.85M-7.59M
Net Cash Flow
-3.64M-4.93M-7.10M17.23M-5.64M-4.22M6.78M-7.59M-9.84M-1.44M15.88M-9.27M11.88M-7.14M14.51M-3.10M18.99M27.49M35.30M31.25M